Literature DB >> 19572061

Clopidogrel response variability: current status and future directions.

José Luis Ferreiro1, Dominick J Angiolillo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19572061     DOI: 10.1160/TH09-03-0185

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  18 in total

1.  Immature platelet fraction (IPF) determined with an automated method predicts clopidogrel hyporesponsiveness.

Authors:  Homam Ibrahim; Srinivas Nadipalli; Timothy DeLao; Sasidhar Guthikonda; Neal S Kleiman
Journal:  J Thromb Thrombolysis       Date:  2012-02       Impact factor: 2.300

Review 2.  Late stent thrombosis: the last remaining obstacle in coronary interventional therapy.

Authors:  Piera Capranzano; George Dangas
Journal:  Curr Cardiol Rep       Date:  2012-08       Impact factor: 2.931

3.  Allele frequency distribution of CYP2C19*2 allelic variants associated with clopidogrel resistance in cardiac patients.

Authors:  Kashif Ur Rehman; Tanveer Akhtar; Muhammad Farooq Sabar; Muhammad Akram Tariq
Journal:  Exp Ther Med       Date:  2015-05-14       Impact factor: 2.447

Review 4.  Role of New Antiplatelet Drugs on Cardiovascular Disease: Update on Cangrelor.

Authors:  Ana Lucrecia Marcano; José Luis Ferreiro
Journal:  Curr Atheroscler Rep       Date:  2016-11       Impact factor: 5.113

5.  Impact of impaired glucose tolerance on clopidogrel response in patients with coronary artery disease.

Authors:  Masafumi Ueno; Kosuke Fujita; Hiroyuki Yamamoto; Tomoyuki Ikeda; Tatsuya Suga; Kenji Yamaji; Shinichiro Ikuta; Kazuhiro Kobuke; Yoshitaka Iwanaga; Dominick J Angiolillo; Shunichi Miyazaki
Journal:  J Thromb Thrombolysis       Date:  2015-08       Impact factor: 2.300

Review 6.  Effect of intrinsic and extrinsic factors on the clinical pharmacokinetics and pharmacodynamics of prasugrel.

Authors:  David S Small; Nagy A Farid; Christopher D Payne; Christopher S Konkoy; Joseph A Jakubowski; Kenneth J Winters; Daniel E Salazar
Journal:  Clin Pharmacokinet       Date:  2010-12       Impact factor: 6.447

Review 7.  Gender differences in cardiovascular therapy: focus on antithrombotic therapy and percutaneous coronary intervention.

Authors:  Juan Luis Gutiérrez-Chico; Julinda Mehilli
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

8.  Prasugrel versus clopidogrel in stent-assisted coil embolization of unruptured intracranial aneurysms.

Authors:  Jacques Sedat; Yves Chau; Jean Gaudart; Marina Sachet; Stephanie Beuil; Michel Lonjon
Journal:  Interv Neuroradiol       Date:  2016-10-22       Impact factor: 1.610

Review 9.  Antiplatelet therapy for atherothrombotic disease: how can we improve the outcomes?

Authors:  Martin Moser; Christoph Bode
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

Review 10.  Platelet function profiles in patients with diabetes mellitus.

Authors:  Fabiana Rollini; Francesco Franchi; Ana Muñiz-Lozano; Dominick J Angiolillo
Journal:  J Cardiovasc Transl Res       Date:  2013-02-13       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.